Skip to Content

Augstas Jaudas Medicīniskie Lāzeri

Jau vairāk nekā 30 gadus mēs veicinām medicīniskās lāzertehnoloģijas attīstību.
Mūsu lāzeri Kontakti
SURGERY
AESTHETICS
DERMATOLOGY
GYNECOLOGY
ENDOSCOPY

LINLINE Medical Systems SIA

Mēs nodarbojamies ar medicīnisko lāzeru projektēšanu un ražošanu, kā arī ar efektīvu lāzerterapijas metožu izstrādi. Mēs sadarbojamies ar medicīniskās pētniecības organizācijām, ārstniecības centriem, zinātnes un tehnikas speciālistiem, kuri ir ieinteresēti modernu lāzertehnoloģiju attīstībā un popularizēšanā medicīnā.

 

 

 

 

 

30 Years of Excellence in Medical Laser Solutions

In-house development

From product design to treatment methods, every stage is developed internally and supported by continuous clinical feedback.

In-house manufacturing

A full-cycle production process, supported by an ISO 13485 quality management system for medical laser devices.

Quick Links

Сontact us with any questions or feedback


Customer Service

Customer Service

Service requests, customer portal and community.
See more


Customer Service

Distributors

Find a distributor, terms of sale, price request.
See more


Customer Service

Partnership

If you're interested in partrering with us, we would love to hear from you.
See more

30 years of research, engineering,
and clinical expertise in one
advanced medical laser platform

MULTILINE™
 

MULTILINE™ is LINLINE’s modular, multi-application laser platform built around a universal base unit with external high-power emitters. One system can support dermatology, aesthetic medicine, and surgery—so clinics start with the treatments they need now and simply add emitters as they grow.

Laser emitters (overview)

Here is the quick map of what the platform supports

Nd:YAP/KTP 540/1079nm (Q-switched)

Dual-wavelength work for vascular indications and selected tattoo colors; foundation for Target Creation Technology®.

Ruby 694nm (Q-switched)

pigmented lesions and certain tattoo pigments.

Alexandrite 755nm (Q-switched)

pigment work and green/blue tattoo inks.

Nd:YAP 1079nm (Q-switched)

QOOL-epilation® hair removal and dark/blue tattoo work.

Nd:YAP 1079/1340/1440nm

long-pulse contact scalpel; soft-tissue vaporisation with controlled hemostasis.

Er:YAG 2936nm

non-contact ablation (layer-by-layer removal with minimal residual coagulation).

Er:YAG 2936nm + RecoSMA

patented spatially modulated ablation for rejuvenation, scars, and wound healing.

Vascular Lesions Treatment

Target Creation Technology™ - transdermal coagulation of dilated blood vessels

How it works Demo request

Benefits for practitioners and patients

One platform, many treatments

From vascular and pigment work to hair removal, tattoos, scars, rejuvenation, and soft-tissue surgery—on a single base unit. That simplifies staff training, room setup, and maintenance.

Upgradeable

Add emitters as demand grows; no need to replace the base unit to launch a new service line.

Consistent outcomes

Stable output and pre-set programs support reproducible results; experts highlight MULTILINE’s RecoSMA capability as a differentiator.

Compliance support

LINLINE lists ISO 13485 and CE documentation online for procurement teams.

Example clinical areas (delivered by different emitters)

Dermatology & aesthetics

rosacea/telangiectasias (TCT), lentigines & melasma (Pinpoint Coagulation), hair removal (QOOL), tattoos (DAW), rejuvenation and scars (RecoSMA).

Surgery & ENT/oral

Er:YAG ablation and Nd:YAP vaporisation with controlled hemostasis for soft tissues.

Wound care

ablative sanitation with Er:YAG plus RecoSMA-driven regeneration; documented across case reports and clinician testimonials.

With its base unit + external emitter concept, MULTILINE™ gives clinics a future-proof way to deliver many laser procedures on a single platform—combining reliable performance for practitioners with comfortable, effective care for patients

On the 10th of October 2024 LINLINE Medical Systems SIA has signed an agreement Nr. 17.1-1-L-2024/436 with Investment and Development Agency of Latvia (LIAA) for the project "Development of Innovative Entrepreneurship of SMEs" (ID Nr. 1.2.3.1/1/23/I/001), which is co-financed by the European Regional Development Fund.